BME 6230

BME 6230

Course information provided by the Courses of Study 2021-2022.

Cancer and immunology had been investigated separately for a long time. Recently, they have become connected to each other as we appreciated the roles of immunity in cancer formation, progression, and treatment. As cancer immunotherapies are emerging, understanding of cancer and immunity in deeper manners as a separate topic is required, but also, the abilities to combine both topics in physiologically relevant contexts and relevant knowledge in bioengineering approaches (biomaterials, drug delivery systems, tissue engineering) are needed to be able to solve the multifactorial disease. In this course, we will discuss the topics in Cancer Engineering (module 1); Immune Engineering (module 2); and Cancer Immunotherapy (module 3). In each module, critical biological concepts will be discussed, followed by engineering perspectives, and updated case studies from experts in the cancer and immune-engineering field.

When Offered Spring.

Permission Note Enrollment limited to: graduate students.

Outcomes
  • Students will be able to recognize the importance of the key biological and engineering concepts in cancer, immunity, and cancer immunotherapy.
  • Students will be able to explain molecular components and mechanisms by which cancer cells and immune cells respond to their environments.
  • Students will be able to identify suitable engineering tools and approaches (biomaterials, drug delivery, tissue engineering) to investigate cancer immunotherapy and interpret representative experimental data.

View Enrollment Information

Syllabi:
  •   Regular Academic Session. 

  • 3 Credits Graded

  • 20343 BME 6230   LEC 001

  • Instruction Mode: In Person